215 related articles for article (PubMed ID: 17612853)
1. Are there any differences in the efficacy among second generation antipsychotics in the treatment of schizophrenia and related disorders?
Motlová L; Spaniel F; Höschl C; Balon R
Ann Clin Psychiatry; 2007; 19(2):133-43. PubMed ID: 17612853
[TBL] [Abstract][Full Text] [Related]
2. Selection of atypical antipsychotics for the management of schizophrenia.
Sprague DA; Loewen PS; Raymond CB
Ann Pharmacother; 2004 Feb; 38(2):313-9. PubMed ID: 14742771
[TBL] [Abstract][Full Text] [Related]
3. Quality of life in the long-term treatment and the role of second-generation antipsychotics.
Mohr P
Neuro Endocrinol Lett; 2007 Feb; 28 Suppl 1():117-33. PubMed ID: 17262004
[TBL] [Abstract][Full Text] [Related]
4. Tolerability of atypical antipsychotics in the treatment of adults with schizophrenia or bipolar disorder: a mixed treatment comparison of randomized controlled trials.
Edwards SJ; Smith CJ
Clin Ther; 2009 Jun; 31 Pt 1():1345-59. PubMed ID: 19698898
[TBL] [Abstract][Full Text] [Related]
5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
6. Atypical antipsychotic drugs: current issues of safety and efficacy in the management of schizophrenia.
Vohora D
Curr Opin Investig Drugs; 2007 Jul; 8(7):531-8. PubMed ID: 17659473
[TBL] [Abstract][Full Text] [Related]
7. A meta-analysis of the efficacy of second-generation antipsychotics.
Davis JM; Chen N; Glick ID
Arch Gen Psychiatry; 2003 Jun; 60(6):553-64. PubMed ID: 12796218
[TBL] [Abstract][Full Text] [Related]
8. Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).
Jones PB; Barnes TR; Davies L; Dunn G; Lloyd H; Hayhurst KP; Murray RM; Markwick A; Lewis SW
Arch Gen Psychiatry; 2006 Oct; 63(10):1079-87. PubMed ID: 17015810
[TBL] [Abstract][Full Text] [Related]
9. Cognitive and psychomotor effects of risperidone in schizophrenia and schizoaffective disorder.
Houthoofd SA; Morrens M; Sabbe BG
Clin Ther; 2008 Sep; 30(9):1565-89. PubMed ID: 18840365
[TBL] [Abstract][Full Text] [Related]
10. Sexual dysfunction in schizophrenia: focus on recent evidence.
Baggaley M
Hum Psychopharmacol; 2008 Apr; 23(3):201-9. PubMed ID: 18338766
[TBL] [Abstract][Full Text] [Related]
11. Second generation antipsychotics for schizophrenia.
Feltus MS; Gardner DM
Can J Clin Pharmacol; 1999; 6(4):187-95. PubMed ID: 10601752
[TBL] [Abstract][Full Text] [Related]
12. Dropout rates in placebo-controlled and active-control clinical trials of antipsychotic drugs: a meta-analysis.
Kemmler G; Hummer M; Widschwendter C; Fleischhacker WW
Arch Gen Psychiatry; 2005 Dec; 62(12):1305-12. PubMed ID: 16330718
[TBL] [Abstract][Full Text] [Related]
13. Efficacy, safety, and tolerability of quetiapine in patients with schizophrenia.
Nasrallah HA; Tandon R
J Clin Psychiatry; 2002; 63 Suppl 13():12-20. PubMed ID: 12562142
[TBL] [Abstract][Full Text] [Related]
14. Off-label second generation antipsychotics for impulse regulation disorders: a review.
Scheltema Beduin A; de Haan L
Psychopharmacol Bull; 2010; 43(3):45-81. PubMed ID: 21150846
[TBL] [Abstract][Full Text] [Related]
15. Paliperidone extended-release tablets for the acute and maintenance treatment of schizophrenia.
Fowler JA; Bettinger TL; Argo TR
Clin Ther; 2008 Feb; 30(2):231-48. PubMed ID: 18343262
[TBL] [Abstract][Full Text] [Related]
16. Use of atypical antipsychotics in the treatment of autistic disorder.
Stachnik JM; Nunn-Thompson C
Ann Pharmacother; 2007 Apr; 41(4):626-34. PubMed ID: 17389666
[TBL] [Abstract][Full Text] [Related]
17. Choice of maintenance medication for schizophrenia.
Davis JM; Chen N
J Clin Psychiatry; 2003; 64 Suppl 16():24-33. PubMed ID: 14680416
[TBL] [Abstract][Full Text] [Related]
18. [Problems in evaluating new antipsychotic drugs].
Fleischhacker WW
Wien Med Wochenschr; 1998; 148(11-12):266-72. PubMed ID: 9746969
[TBL] [Abstract][Full Text] [Related]
19. Effectiveness and cost of atypical versus typical antipsychotic treatment for schizophrenia in routine care.
Stargardt T; Weinbrenner S; Busse R; Juckel G; Gericke CA
J Ment Health Policy Econ; 2008 Jun; 11(2):89-97. PubMed ID: 18509216
[TBL] [Abstract][Full Text] [Related]
20. A meta-analysis of head-to-head comparisons of second-generation antipsychotics in the treatment of schizophrenia.
Leucht S; Komossa K; Rummel-Kluge C; Corves C; Hunger H; Schmid F; Asenjo Lobos C; Schwarz S; Davis JM
Am J Psychiatry; 2009 Feb; 166(2):152-63. PubMed ID: 19015230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
